Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Protalix BioTherapeutics (PLX) over the last 17 years, with Q3 2025 value amounting to $549000.0.

  • Protalix BioTherapeutics' Other Non-Current Assets fell 213.9% to $549000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $549000.0, marking a year-over-year decrease of 213.9%. This contributed to the annual value of $462000.0 for FY2024, which is 1250.0% down from last year.
  • Per Protalix BioTherapeutics' latest filing, its Other Non-Current Assets stood at $549000.0 for Q3 2025, which was down 213.9% from $520000.0 recorded in Q2 2025.
  • Protalix BioTherapeutics' Other Non-Current Assets' 5-year high stood at $2.1 million during Q4 2021, with a 5-year trough of $459000.0 in Q1 2025.
  • For the 5-year period, Protalix BioTherapeutics' Other Non-Current Assets averaged around $1.1 million, with its median value being $1.3 million (2023).
  • Per our database at Business Quant, Protalix BioTherapeutics' Other Non-Current Assets surged by 1885.3% in 2021 and then crashed by 5832.68% in 2023.
  • Quarter analysis of 5 years shows Protalix BioTherapeutics' Other Non-Current Assets stood at $2.1 million in 2021, then plummeted by 39.0% to $1.3 million in 2022, then tumbled by 58.33% to $528000.0 in 2023, then dropped by 12.5% to $462000.0 in 2024, then grew by 18.83% to $549000.0 in 2025.
  • Its Other Non-Current Assets stands at $549000.0 for Q3 2025, versus $520000.0 for Q2 2025 and $459000.0 for Q1 2025.